Footnotes
This manuscript has recently been accepted for publication in the ERJ Open Research. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJOR online. Please open or download the PDF to view this article.
Conflict of interest: Michael Loebinger reports the following relationships outside the submitted work; consulting fees received from Insmed, Savara, Parion, Armata, Chiesi, Zambon and Astra Zeneca; lecture fees received from Grifols and Insmed; infection group chair for the European Respiratory Society. The remaining authors have nothing to disclose.
This is a PDF-only article. Please click on the PDF link above to read it.
- Received September 3, 2022.
- Accepted October 16, 2022.
- Copyright ©The authors 2022
This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions{at}ersnet.org
